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   Resilon	  obturation	  system	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  discontinued	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  its	  introduction	  as	  an	  alternative	  to	  traditional	  gutta	  percha	  and	  sealer.	  In-­‐vitro	  models	  support	  anecdotal	  reports	  of	  degraded	  Resilon	  filling	  material.	  This	  may	  represent	  a	  significant	  health	  concern	  for	  the	  patient.	  The	  aim	  of	  this	  study	  was	  to	  determine	  the	  proportion	  of	  Resilon	  degradation	  in	  non-­‐healed	  endodontic	  cases	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  to	  present	  a	  case	  series	  describing	  retreatments	  of	  non-­‐healed	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  teeth.	  Patients	  previously	  treated	  with	  Resilon	  (R)	  or	  Gutta-­‐Percha	  (GP)	  that	  had	  a	  non-­‐healed	  canal	  that	  needed	  a	  retreatment	  were	  enrolled.	  The	  proportion	  of	  degraded	  filling	  material	  was	  statistically	  significantly	  different	  between	  R	  and	  GP	  treated	  groups	  (p=.0003)	  with	  78%	  of	  R	  canals	  being	  degraded	  compared	  to	  0%	  of	  GP	  canals.	  The	  difference	  in	  the	  proportionality	  of	  degradation	  between	  the	  two	  materials	  was	  marginally	  significant	  (p=.054)	  when	  dichotomized	  time	  to	  follow-­‐up	  and	  presence	  of	  an	  orifice	  barrier	  were	  controlled	  for	  in	  the	  multivariate	  analysis.	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THESIS	  INTRODUCTION	  	  	   Endodontic	  success	  relies	  on	  the	  ability	  to	  eliminate	  bacteria	  from	  the	  root	  canal	  system	  and	  to	  create	  a	  fluid	  tight	  seal	  within	  the	  canal	  space	  (1).	  Endodontic	  therapy	  may	  be	  initiated	  for	  a	  variety	  of	  reasons	  including	  trauma,	  carious	  pulpal	  exposure,	  mechanical	  pulpal	  exposure,	  and	  restorative	  needs,	  however	  the	  goal	  of	  sealing	  and	  disinfecting	  the	  root	  canal	  system	  remains.	  Following	  chemomechanical	  preparation,	  adequate	  obturation	  is	  required	  to	  prevent	  future	  reinfection.	  Obturation	  of	  root	  canals	  traditionally	  involves	  the	  use	  of	  gutta	  percha	  in	  combination	  with	  a	  sealing	  cement	  (2).	  Gutta	  percha	  was	  first	  used	  by	  Bowman	  as	  a	  root	  canal	  filling	  material	  in	  1867	  and	  is	  still	  the	  most	  widely	  used	  obturation	  core	  in	  endodontics	  (3).	  Despite	  its	  popularity,	  the	  material	  has	  several	  shortcomings	  that	  may	  contribute	  to	  endodontic	  failure.	  Some	  of	  these	  include	  shrinkage	  after	  cooling	  and	  lack	  of	  adhesion	  that	  may	  result	  in	  bacterial	  leakage	  (4,5).	  Due	  to	  these	  shortcomings,	  various	  modifications	  to	  gutta	  purcha	  have	  been	  explored	  to	  improve	  its	  physical	  and	  chemical	  properties.	  Alternatives	  to	  gutta	  percha	  have	  also	  been	  developed	  that	  bond	  to	  dentin	  to	  eliminate	  interfacial	  gaps	  and	  create	  a	  bacterial	  resistant	  seal	  (6).	  Still,	  there	  remains	  little	  published	  evidence	  on	  intracanal	  adhesion	  and	  the	  advantages/	  disadvantages	  over	  traditionally	  used	  gutta	  percha.	  In	  vitro	  studies	  have	  demonstrated	  complications	  with	  intracanal	  bonding	  including	  stresses	  due	  to	  polymerization	  shrinkage	  resulting	  from	  a	  high	  cavity	  configuration	  factor	  (C-­‐factor).	  These	  shrinkage	  stresses	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complicate	  the	  formation	  of	  high-­‐	  strength	  bonds	  within	  the	  canal,	  which	  may	  result	  in	  decreased	  retention	  and	  increased	  marginal	  leakage	  (7,8).	  	   Resilon	  is	  a	  thermoplastic	  synthetic	  polymer	  based	  root	  canal	  filling	  material	  that	  was	  introduced	  as	  a	  replacement	  for	  gutta	  percha	  in	  2004	  (9).	  It	  is	  composed	  of	  a	  parent	  polymer,	  a	  biodegradable	  aliphatic	  polyester	  called	  polycaprolactone,	  	  bioactive	  glass,	  methacrylate	  resin,	  barium	  sulphate,	  and	  bismuth	  oxychloride	  (10).	  Resilon	  handles	  similarly	  to	  gutta	  percha,	  and	  can	  be	  dissolved	  by	  solvents	  during	  retreatment	  (10).	  It	  is	  used	  in	  conjunction	  with	  Epiphany,	  a	  methacrylate-­‐	  based	  sealer,	  and	  a	  self-­‐	  etching	  primer	  (9).	  These	  products,	  when	  used	  in	  combination,	  were	  designed	  to	  form	  a	  monoblock	  with	  the	  primed	  dentin,	  resulting	  in	  an	  alleged	  superior	  obturation	  resistant	  to	  bacterial	  leakage	  (11)	  and	  increased	  fracture	  resistance	  of	  the	  root	  canal	  treated	  tooth	  (12).	  	  	   Although	  initial	  studies	  showed	  Resilon	  having	  improved	  characteristics	  over	  traditional	  gutta	  percha	  (11,13),	  several	  in	  vitro	  studies	  have	  since	  reported	  otherwise.	  	  The	  idea	  of	  a	  monoblock	  has	  been	  challenged	  due	  to	  the	  unpredictability	  of	  the	  Epiphany/dentin	  bond,	  which	  was	  shown	  to	  result	  in	  significantly	  more	  gap	  formation	  at	  the	  dentin-­‐	  sealer	  interface	  than	  AH	  Plus/	  gutta	  percha	  fillings	  (14).	  In	  a	  rat	  subcutaneous	  implantation	  model,	  Resilon	  showed	  inferior	  long-­‐term	  biocompatibility	  when	  compared	  to	  a	  gutta	  percha	  control	  (15).	  Its	  believed	  that	  Resilon’s	  cytotoxicity	  may	  be	  due	  to	  its	  biodegradability	  (16).	  	  The	  Resilon	  polymeric	  matrix	  consists	  of	  25-­‐40%	  polycaprolactone	  (PCL)	  and	  3-­‐10%	  dimethacrylates	  (17–19).	  PCL	  accounts	  for	  Resilon’s	  thermoplasticity	  and	  is	  susceptible	  to	  biodegradation	  through	  the	  cleavage	  of	  ester	  bonds	  (16).	  Its	  inclusion	  in	  the	  Resilon	  formulation	  has	  caused	  concern.	  In	  a	  series	  of	  in	  vitro	  studies,	  Tay	  et.	  al	  demonstrated	  the	  biodegradation	  of	  Resilon	  and	  PCL	  in	  the	  presence	  of	  abiotic	  factors	  such	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as	  alkaline	  hydrolases	  and	  biotic	  factors	  including	  endodontically	  relevant	  bacteria	  and	  fungi	  (16,20,21).	  When	  compression	  molded	  into	  disks,	  both	  Resilon	  and	  PCL	  exhibited	  significant	  surface	  pitting	  and	  erosion	  compared	  to	  gutta	  percha	  following	  incubation	  in	  dental	  sludge	  for	  4	  months	  (16).	  Emulsified	  Resilon	  was	  shown	  to	  degrade	  in	  the	  presence	  of	  cholesterol	  esterase,	  a	  component	  of	  salivary	  hydrolases	  and	  an	  inflammatory–cell	  derived	  enzyme	  (20).	  	  	   The	  significance	  of	  Resilon’s	  susceptibility	  to	  biodegradation	  as	  demonstrated	  in	  the	  before	  mentioned	  studies,	  is	  its	  potential	  impact	  on	  outcome	  of	  Resilon	  obturated	  root	  canals.	  A	  recent	  study	  comparing	  long-­‐term	  clinical	  outcomes	  found	  that	  Resilon	  had	  5.7	  times	  greater	  odds	  of	  failure	  compared	  with	  gutta	  percha	  (22).	   Of the Resilon obturated 
teeth, 56% were classified as successful compared to 88% of gutta percha obturated teeth (22).	  The	  biodegradation	  of	  Resilon	  as	  demonstrated	  in	  in	  vitro	  models	  may	  present	  a	  potential	  explanation	  for	  this	  higher	  clinical	  failure	  rate.	  Should	  a	  non-­‐healed	  Resilon	  filled	  tooth	  require	  a	  retreatment,	  significant	  concern	  also	  exists	  over	  the	  increased	  possibility	  of	  experiencing	  a	  flare-­‐up	  due	  to	  the	  potentially	  degraded	  status	  of	  the	  Resilon.	  	   While	  most	  patients	  return	  to	  normal	  function	  and	  experience	  a	  significant	  relief	  of	  pain	  following	  endodontic	  therapy,	  some	  patients	  may	  experience	  an	  acute	  exacerbation	  of	  severe	  pain	  and/or	  swelling	  requiring	  an	  unscheduled	  visit	  and	  active	  treatment	  known	  as	  a	  flare-­‐up	  (23).	  Though	  this	  occurrence	  is	  rare,	  it	  is	  still	  a	  significant	  concern	  for	  both	  the	  patient	  and	  the	  provider.	  Several	  factors	  have	  been	  recognized	  as	  predisposing	  patients	  to	  flare-­‐ups.	  Walton	  and	  Fouad	  found	  positive	  correlations	  between	  flare-­‐ups	  and	  pre-­‐operative	  diagnosis	  of	  pulpal	  necrosis	  with	  symptomatic	  apical	  pathosis	  and	  patients	  with	  pre-­‐operative	  pain	  and/or	  swelling	  (23).	  Specific	  bacterial	  species	  (24),	  periapical	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radiolucencies	  (25),	  the	  number	  of	  visits,	  tooth	  type,	  allergies,	  and	  patient	  demographics	  including	  sex	  and	  age	  are	  all	  factors	  shown	  to	  be	  associated	  with	  endodontic	  flare-­‐ups	  (26).	  Retreatments	  have	  also	  been	  associated	  with	  a	  higher	  prevalence	  of	  inter-­‐appointment	  emergencies	  (26–28).	  Azim	  et	  al.	  found	  that	  previously	  treated	  teeth	  resulted	  in	  more	  than	  four	  times	  the	  rate	  of	  flare-­‐ups	  compared	  to	  vital	  teeth	  (28).	  A	  study	  looking	  at	  retreatments	  of	  teeth	  with	  resorcinol-­‐formaldehyde	  fillings	  noted	  a	  higher	  than	  normal	  incidence	  of	  flare-­‐ups	  (29).	  These	  findings	  may	  be	  attributed	  to	  acute	  periapical	  inflammation	  caused	  by	  microbial	  factors	  including	  apical	  extrusion	  of	  infected	  debri,	  changes	  in	  endodontic	  microbiota	  or	  in	  environmental	  conditions	  due	  to	  incomplete	  chemo-­‐mechanical	  preparation,	  increase	  of	  the	  oxidation-­‐	  reduction	  potential,	  or	  due	  to	  changes	  in	  local	  adaptation	  syndrome,	  mechanical	  irritation	  from	  overinstrumentation,	  extrusion	  of	  irrigating	  solutions,	  or	  extrusion	  of	  cytotoxic	  filling	  materials	  (30-­‐32).	  	  	   While	  the	  Barborka	  et.	  al	  study	  identified	  a	  higher	  clinical	  failure	  rate	  of	  Resilon,	  there	  remains	  a	  gap	  in	  knowledge	  as	  to	  the	  cause	  of	  Resilon	  failures	  (22).	  The	  in	  vitro	  studies	  mentioned	  previously	  provide	  hypotheses	  including	  the	  susceptibility	  of	  Resilon	  and	  its	  components	  to	  degradation,	  however	  there	  is	  no	  previous	  clinical	  proof	  of	  this	  degradation.	  The	  aim	  of	  this	  study	  is	  to	  identify	  the	  proportion	  of	  degradation	  of	  Resilon	  filling	  material	  in	  non-­‐healed	  retreatment	  cases	  compared	  to	  gutta	  percha.	  We	  also	  present	  a	  case	  series	  of	  Resilon	  retreatments	  illustrative	  of	  the	  clinical	  presentation	  of	  the	  material,	  the	  process	  of	  retreatment,	  and	  the	  occurrence	  of	  flare-­‐ups.	  These	  findings	  will	  be	  significant	  in	  providing	  information	  to	  guide	  the	  practitioner	  in	  future	  treatment	  planning	  of	  Resilon	  filled	  teeth,	  such	  as	  the	  decision	  between	  retreatment	  versus	  periapical	  microsurgery.	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MANUSCRIPT	  1:	  RESILON:	  ASSESSMENT	  OF	  DEGRADED	  FILLING	  MATERIAL	  IN	  NON-­‐
HEALED	  CASES	  	  	  
Introduction	  	  	   Resilon	  is	  a	  thermoplastic	  synthetic	  polymer	  based	  root	  canal	  filling	  material	  that	  was	  introduced	  as	  a	  replacement	  for	  traditionally	  used	  gutta	  percha	  in	  2004	  (1).	  It	  is	  composed	  of	  a	  parent	  polymer,	  a	  biodegradable	  aliphatic	  polyester	  called	  polycaprolactone,	  	  bioactive	  glass,	  methacrylate	  resin,	  barium	  sulphate,	  and	  bismuth	  oxychloride	  (2).	  Resilon	  handles	  similarly	  to	  gutta	  percha,	  and	  can	  be	  dissolved	  by	  solvents	  during	  retreatment	  (2).	  It	  is	  used	  in	  conjunction	  with	  Epiphany,	  a	  methacrylate-­‐	  based	  sealer,	  and	  a	  self-­‐	  etching	  primer	  (1).	  These	  products,	  when	  used	  in	  combination,	  were	  designed	  to	  form	  an	  alleged	  monoblock	  with	  the	  primed	  dentin,	  resulting	  in	  a	  superior	  obturation	  resistant	  to	  bacterial	  leakage	  (3)	  and	  increased	  fracture	  resistance	  of	  the	  root	  canal	  treated	  tooth	  (4).	  	  	   Although	  initial	  studies	  showed	  Resilon	  having	  improved	  characteristics	  over	  traditional	  gutta	  percha	  (3,5),	  several	  in	  vitro	  studies	  have	  since	  reported	  otherwise.	  	  The	  idea	  of	  a	  monoblock	  has	  been	  challenged	  due	  to	  the	  unpredictability	  of	  the	  Epiphany/dentin	  bond,	  which	  was	  shown	  by	  De-­‐Deus	  to	  result	  in	  significantly	  more	  gap	  formation	  at	  the	  dentin-­‐	  sealer	  interface	  than	  AH	  Plus/	  gutta	  percha	  fillings	  (6).	  In	  a	  rat	  subcutaneous	  implantation	  model,	  Resilon	  showed	  inferior	  long-­‐	  term	  biocompatibility	  when	  compared	  to	  a	  gutta	  percha	  control	  (7).	  Its	  believed	  that	  Resilon’s	  cytotoxicity	  may	  be	  due	  to	  its	  biodegradability	  (8).	  	  The	  Resilon	  polymeric	  matrix	  consists	  of	  25-­‐	  40%	  polycaprolactone	  (PCL)	  and	  3-­‐	  10%	  dimethacrylates	  (9–11).	  PCL	  accounts	  for	  Resilon’s	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thermoplasticity	  and	  is	  susceptible	  to	  biodegradation	  through	  the	  cleavage	  of	  ester	  bonds	  (8).	  Its	  inclusion	  in	  the	  Resilon	  formulation	  has	  caused	  concern.	  In	  a	  series	  of	  in	  vitro	  studies,	  Tay	  et.	  al	  demonstrated	  the	  biodegradation	  of	  Resilon	  and	  PCL	  in	  the	  presence	  of	  abiotic	  factors	  such	  as	  alkaline	  hydrolases	  and	  biotic	  factors	  including	  endodontically	  relevant	  bacteria	  and	  fungi	  (8,12,13).	  When	  compression	  molded	  into	  disks,	  both	  Resilon	  and	  PCL	  exhibited	  significant	  surface	  pitting	  and	  erosion	  compared	  to	  gutta	  percha	  following	  incubation	  in	  dental	  sludge	  for	  4	  months	  (8).	  Emulsified	  Resilon	  was	  shown	  to	  degrade	  in	  the	  presence	  of	  cholesterol	  esterase,	  a	  component	  of	  salivary	  hydrolases	  and	  an	  inflammatory–cell	  derived	  enzyme	  (12).	  	  	   The	  significance	  of	  Resilon’s	  susceptibility	  to	  biodegradation	  as	  demonstrated	  in	  the	  before	  mentioned	  studies,	  is	  its	  potential	  impact	  on	  outcome	  of	  Resilon	  obturated	  root	  canals.	  A	  recent	  study	  comparing	  long-­‐term	  clinical	  outcomes	  found	  that	  Resilon	  had	  5.7	  times	  greater	  odds	  of	  failure	  compared	  with	  gutta	  percha	  (14).	  While	  a	  higher	  clinical	  failure	  rate	  has	  been	  identified,	  there	  remains	  a	  gap	  in	  knowledge	  as	  to	  the	  cause	  of	  Resilon	  failures	  (20).	  The	  in	  vitro	  studies	  mentioned	  previously	  provide	  hypotheses	  including	  the	  susceptibility	  of	  Resilon	  and	  its	  components	  to	  degradation,	  however	  there	  is	  no	  previous	  clinical	  proof	  of	  this	  degradation.	  The	  aim	  of	  this	  study	  is	  to	  identify	  the	  proportion	  of	  degradation	  of	  Resilon	  filling	  material	  in	  non-­‐	  healed	  retreatment	  cases	  compared	  to	  gutta	  percha.	  	  
Materials	  and	  Methods	  	   Institutional	  Review	  Board	  approval	  for	  this	  clinical	  observational	  study	  conducted	  in	  the	  Graduate	  Endodontic	  Clinic	  at	  the	  School	  of	  Dentistry	  was	  obtained	  at	  the	  University	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of	  North	  Carolina	  at	  Chapel	  Hill	  (#16-­‐1069).	  	  	  Patients	  who	  were	  18	  years	  or	  older,	  ASA	  classification	  I	  or	  II,	  whose	  primary	  treatment	  included	  use	  of	  Resilon	  with	  Epiphany	  sealer	  or	  gutta	  percha	  and	  AH-­‐Plus	  sealer	  as	  the	  obturation	  material,	  and	  whose	  treatment	  was	  completed	  in	  either	  the	  predoctoral	  or	  graduate	  endodontic	  practices	  at	  University	  of	  North	  Carolina	  School	  of	  Dentistry	  (UNC-­‐SOD)	  during	  the	  time	  period	  of	  08/2004	  -­‐	  08/2013	  were	  identified	  through	  a	  search	  of	  the	  electronic	  patient	  record.	  	  Patient’s	  whose	  dental	  records	  did	  not	  objectively	  indicate	  which	  material	  was	  used	  for	  obturation	  (Resilon	  or	  gutta	  percha)	  or	  whose	  dental	  records	  did	  not	  contain	  an	  adequate	  post-­‐	  operative	  radiograph	  of	  the	  primary	  root	  canal	  treatment	  were	  excluded.	  	   Five	  hundred	  eighty	  patients	  were	  randomly	  selected	  from	  a	  pool	  of	  7,376	  possible	  patients	  identified	  in	  the	  electronic	  patient	  record	  search.	  	  A	  telephone	  call	  was	  made	  to	  the	  580	  randomly	  selected	  patients	  at	  the	  phone	  numbers	  registered	  in	  the	  database.	  If	  there	  was	  no	  answer,	  a	  scripted	  voice	  message	  was	  left	  and	  the	  secondary	  number	  on	  file	  was	  then	  called.	  Thirty eight patients agreed to come into the endodontic clinic for a follow-up 
examination. Of the 38 patients, 11 were determined to have	  a	  non-­‐healed	  root	  canal	  requiring	  retreatment	  based	  on	  the	  follow-­‐up	  examination	  described	  below.	  
	  
Follow-­‐	  up	  Examination	  	  	   Follow-­‐	  up	  examinations	  were	  performed	  by	  one	  of	  two	  endodontic	  residents	  at	  UNC-­‐SOD	  under	  the	  supervision	  of	  a	  board	  certified	  endodontist.	  	  The	  patient	  was	  assigned	  a	  study	  ID	  #	  under	  which	  the	  following	  data	  were	  recorded	  on	  a	  standardized	  assessment	  form:	  age,	  gender,	  tooth	  type	  (anterior,	  premolar,	  molar),	  time	  since	  completion	  of	  previous	  root	  canal	  treatment,	  type	  of	  initial	  filling	  material	  (Resilon	  or	  gutta	  percha).
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   A	  head	  and	  neck	  exam	  and	  intra	  oral	  evaluation	  were	  performed.	  Endodontic	  diagnostic	  tests	  were	  completed	  including	  percussion	  and	  palpation	  testing,	  tooth	  slooth	  response,	  and	  probing	  depth	  measurements.	  A	  periapical	  radiograph	  (PA)	  was	  taken	  at	  an	  angle	  similar	  to	  the	  original	  post-­‐	  operative	  radiograph.	  	  A	  tooth	  was	  considered	  non-­‐healed	  if	  the	  patient	  presented	  with	  signs	  or	  symptoms	  of	  infection	  or	  if	  there	  was	  a	  periapical	  lesion	  of	  the	  same	  or	  larger	  size	  than	  in	  the	  original	  post-­‐operative	  radiograph.	  
	  
Retreatment	  
	   Patients	  identified	  as	  requiring	  retreatment	  were	  assigned	  to	  one	  of	  two	  endodontic	  residents	  by	  front	  desk	  personnel	  at	  UNC-­‐SOD.	  Patients	  signed	  the	  standardized	  UNC-­‐SOD	  consent	  form	  for	  endodontic	  treatment	  as	  well	  as	  consent	  to	  participate	  in	  the	  study	  and	  HIPAA	  Authorization.	  Patients	  were	  given	  the	  opportunity	  to	  ask	  the	  investigator	  questions	  concerning	  treatment.	  The	  retreatment	  began	  with	  local	  anesthesia	  based	  on	  the	  individual	  needs	  of	  the	  subject.	  The	  investigator	  isolated	  the	  tooth	  to	  be	  retreated	  with	  a	  single	  punch	  rubber	  dam.	  The	  rubber	  dam	  was	  disinfected	  before	  and	  after	  access	  with	  4%	  NaOCl.	  After	  adequate	  anesthesia	  and	  isolation,	  the	  investigator	  removed	  any	  carious	  tooth	  structure	  or	  compromised	  restorations.	  The	  tooth	  was	  then	  accessed	  to	  expose	  the	  filling	  material.	  Upon	  access	  of	  the	  root	  canal	  system,	  the	  investigator	  classified	  the	  Resilon	  or	  gutta	  percha	  filling	  material	  in	  each	  canal	  as	  either	  degraded	  or	  intact.	  Classification	  was	  based	  on	  the	  following	  criteria:	  	  
- Degraded:	  Lack	  of	  solid	  dense	  material	  remaining	  within	  the	  canal	  confirmed	  by	  passively	  placing	  a	  size	  15	  K	  file	  into	  the	  canal	  space	  (i.e.	  it	  does	  not	  cause	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bending	  of	  the	  size	  15	  K	  file)	  (Fig.1).	  
- Intact:	  Presence	  of	  solid	  dense	  filling	  material	  that	  provides	  resistance	  to	  size	  15	  K	  file	  insertion	  resulting	  in	  the	  file	  bending	  (Fig.	  2).	  
The	  following	  clinical	  observations	  were	  recorded	  during	  treatment	  for	  each	  tooth:	  
- Type	  of	  restoration	  (full	  coverage	  or	  not)	  
- Presence	  of	  caries	  	  
- Presence	  of	  a	  missed	  canal	  
- Apical	  stop	  
- Tooth	  discoloration	  
- Presence	  of	  an	  orifice	  barrier	  	   After	  documentation	  of	  the	  findings,	  the	  investigator	  continued	  with	  the	  retreatment,	  which	  was	  completed	  over	  two-­‐visits	  with	  inter-­‐appointment	  calcium	  hydroxide.	  	  	  	  	   	  	  	  	  	  	  
	   	   	   	   	  13	  
	  
	  
Figure	  1:	  Degraded	  Resilon	  filling	  material.	  Note	  the	  passive	  insertion	  of	  the	  15K	  file	  	  	  
	  
Figure	  2:	  Intact	  GP	  filling	  material.	  Note	  the	  resistance	  to	  insertion	  of	  the	  15K	  file	  resulting	  in	  bending	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Statistical	  Analysis	  	  	   A	  power	  analysis	  indicated	  that	  a	  Fisher’s	  exact	  test	  with	  a	  0.05	  two-­‐sided	  significance	  level	  would	  have	  greater	  than	  80%	  power	  to	  detect	  a	  difference	  in	  proportions	  of	  0.70	  when	  the	  sample	  size	  in	  each	  group	  was	  10.	  	  	  	  	   Fisher’s	  exact	  test	  was	  used	  to	  compare	  the	  demographics	  and	  clinical	  characteristics	  of	  the	  two	  materials	  (Resilon	  or	  gutta	  percha)	  and	  to	  assess	  the	  effect	  of	  material	  and	  demographics	  and	  clinical	  characteristics	  on	  the	  presence	  of	  degradation.	  Logistic	  Regression	  using	  likelihood	  ratio	  tests	  in	  PROC	  GENMOD	  (SAS	  ®	  Vers	  9.3)	  was	  used	  to	  assess	  the	  effect	  of	  three	  variables	  (obturation	  material,	  presence	  of	  an	  orifice	  barrier,	  and	  time	  since	  previous	  treatment	  dichotomized	  at	  the	  median	  time	  of	  all	  subjects	  (TP_N))	  on	  the	  presence	  of	  degradation.	  The	  level	  of	  significance	  was	  established	  at	  p	  <.05.	  	  
Results	  	  	   Out	  of	  38	  patients	  who	  received	  a	  follow-­‐up	  examination,	  11	  met	  the	  criteria	  for	  inclusion,	  totaling	  26	  previously	  treated	  canals	  (18	  Resilon	  and	  8	  gutta	  percha).	  Patients	  were	  predominately	  female	  with	  a	  median	  age	  of	  65	  years	  old	  with	  molar	  teeth	  requiring	  retreatment.	  Patient	  demographics	  (Table	  1)	  and	  clinical	  characteristics	  (Table	  2)	  including	  presence	  of	  a	  full	  coverage	  restoration,	  caries,	  missed	  canals,	  and	  apical	  stop	  were	  not	  found	  to	  be	  statistically	  significantly	  different	  between	  obturation	  materials	  in	  the	  bivariate	  analysis	  (p>.05).	  Dichotomized	  time	  since	  previous	  treatment	  (Table	  3)	  and	  presence	  of	  an	  orifice	  barrier	  (Table	  2)	  were	  statistically	  different	  between	  the	  two	  material	  groups	  (p<.05).	  The	  proportion	  of	  degradation	  between	  the	  two	  materials	  was	  statistically	  significant	  (p=.0003)	  with	  Resilon	  having	  a	  higher	  likelihood	  of	  degradation	  than	  gutta	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percha	  in	  the	  bivariate	  analysis	  (Table	  4).	  Of	  the	  Resilon	  obturated	  canals,	  78%	  were	  degraded	  compared	  to	  0%	  of	  the	  gutta	  percha	  canals.	  The	  bivariate	  analysis	  indicated	  a	  statistically	  significant	  difference	  in	  the	  periapical	  diagnosis	  between	  Resilon	  and	  gutta	  percha	  obturated	  canals	  at	  the	  primary	  treatment	  appointment	  with	  a	  higher	  proportion	  of	  chronic	  apical	  abscesses	  and	  asymptomatic	  apical	  peridodontitis	  among	  Resilon	  canals	  (p<.05).	  However,	  the	  data	  was	  too	  sparse	  to	  include	  in	  the	  logistic	  regression.	  In	  the	  bivariate	  analysis	  where	  degradation	  was	  the	  outcome,	  presence	  of	  an	  orifice	  barrier	  	  (Table	  6)	  was	  the	  only	  variable	  that	  was	  statistically	  significantly	  different	  between	  degraded	  and	  intact	  canals	  (p<.05)	  (Table	  5-­‐7).	  The	  multivariate	  analysis	  indicated	  that	  neither	  presence	  of	  an	  orifice	  barrier	  nor	  dichotomized	  time	  to	  follow-­‐up	  were	  associated	  with	  degradation	  (Table	  8).	  The	  difference	  in	  the	  proportionality	  of	  degradation	  between	  the	  two	  materials	  was	  marginally	  significant	  (p=.054)	  when	  the	  dichotomized	  time	  to	  follow	  up	  and	  presence	  of	  an	  orifice	  barrier	  were	  controlled	  for	  (Table	  8).	  	  	  	  
Material	   Gender	   Tooth	  Type	  
	   Male	   Female	   Anterior	   Premolar	   Molar	  
Resilon	   3	  (33%)	   6	  (67%)	   2	  (11%)	   5	  (28%)	   11	  (61%)	  
Gutta	  Percha	   1	  (33%)	   2	  (67%)	   0	  (0%)	   0	  (0%)	   8	  (100%)	  
p-­‐	  value	   	   0.99	   	   	   0.15	  	  
Table	  1:	  Patient	  demographics	  in	  the	  bivariate	  analysis	  where	  material	  	  (Resilon	  or	  gutta	  percha)	  was	  the	  explanatory	  variable	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Material	  
Full	  Coverage	  
Restoration	   Apical	  Stop	   Caries	   Orifice	  Barrier	   Missed	  Canal	  
	  























































Table	  2:	  Clinical	  characteristics	  in	  the	  bivariate	  analysis	  where	  material	  	  (Resilon	  or	  gutta	  percha)	  was	  the	  explanatory	  variable	  	  	  	  
	  
Material	   Variable	   Lower	  Quartile	   Median	   Upper	  Quartile	  
Resilon	  
























Table	  3:	  Wilcoxon	  Scores	  (Rank	  Sums)	  for	  variable	  age	  and	  time	  since	  	  previous	  treatment	  classified	  by	  variable	  material	  	   	  	  
Material	   Degraded	   Intact	  
Resilon	   14	  (78%)	   4	  (22%)	  
Gutta	  Percha	   0	  (0%)	   8	  (100%)	  
P-­‐Value	   	   0.0003	  	  
Table	  4:	  Degradation	  in	  the	  bivariate	  analysis	  where	  material	  	  (Resilon	  or	  gutta	  percha)	  was	  the	  explanatory	  variable	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Degradation	  Status	   Gender	   Tooth	  Type	  
	   Male	   Female	   Anterior	   Premolar	   Molar	  
Degraded	   5	  (36%)	   9	  (64%)	   2	  (14%)	   4	  (29%)	   8	  (57%)	  
Intact	   6	  (50%)	   6	  (50%)	   0	  (0%)	   1	  (8%)	   11	  (92%)	  
p-­‐	  value	   	   0.69	   	   	   0.13	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Table	  6:	  Clinical	  characteristics	  in	  the	  bivariate	  analysis	  where	  	  degradation	  was	  the	  explanatory	  variable	  	  	  	  
Degradation	  
Status	   Variable	   Lower	  Quartile	   Median	   Upper	  Quartile	  
Degraded	  
Age	  	  	  	  	  	  	  	  	  























Table	  7:	  Wilcoxon	  Scores	  (Rank	  Sums)	  for	  variable	  age	  and	  time	  since	  	  previous	  treatment	  classified	  by	  variable	  degraded	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Source	   DF	   Chi-­‐	  Square	   Pr>ChiSq	  
Material	   1	   3.7	   0.054	  
tp_n	   1	   2.46	   0.12	  
OB	   1	   3.55	   0.06	  	  
Table	  8:	  Likelihood	  Ratio	  Statistics	  for	  Type	  3	  Analysis	  	  	  	  
Discussion	  	   The	  Resilon/	  Epiphany	  obturation	  system	  serves	  as	  an	  example	  as	  to	  the	  difficulties	  surrounding	  bonded	  obturation	  materials.	  There	  remains	  little	  published	  evidence	  on	  intracanal	  adhesion	  and	  the	  advantages/	  disadvantages	  over	  traditionally	  used	  gutta	  percha.	  In	  vitro	  studies	  have	  demonstrated	  complications	  with	  intracanal	  bonding	  including	  stresses	  due	  to	  polymerization	  shrinkage	  resulting	  from	  a	  high	  cavity	  configuration	  factor	  (C-­‐factor).	  These	  shrinkage	  stresses	  complicate	  the	  formation	  of	  high-­‐	  strength	  bonds	  within	  the	  canal	  resulting	  in	  decreased	  retention	  and	  increased	  marginal	  leakage	  (15,	  16).	  While	  initial	  in	  vitro	  studies	  showed	  promising	  results	  including	  improved	  fracture	  resistance	  and	  less	  bacterial	  leakage	  of	  Resilon	  obturated	  root	  canals	  (3,4),	  later	  studies	  showed	  less	  favorable	  results	  including	  degradation	  of	  Resilon	  and	  its	  components	  as	  well	  as	  diminishing	  biocompatibility	  over	  time	  (6,7).	  While	  Resilon	  is	  no	  longer	  in	  use	  clinically,	  its	  effects	  resonate	  in	  the	  patients	  who	  have	  retained	  Resilon	  obturated	  root	  canal	  treated	  teeth.	  	   In	  the	  present	  study,	  non-­‐healed	  cases	  obturated	  with	  Resilon	  had	  a	  higher	  proportion	  of	  degradation	  (78%)	  compared	  to	  those	  obturated	  with	  gutta	  percha	  (0%).	  	  One	  potential	  explanation	  for	  the	  higher	  proportion	  of	  degradation	  may	  be	  the	  inclusion	  of	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polycaprolactone	  (PCL)	  in	  the	  Resilon	  formulation.	  PCL	  is	  a	  biodegradable	  polyester	  responsible	  for	  Resilon’s	  thermoplasticity	  (8).	  	  This	  resorbable	  polymer	  has	  traditionally	  been	  used	  as	  a	  component	  in	  drug-­‐delivery	  devices	  due	  to	  its	  low	  melting	  point,	  biocompatibility,	  and	  susceptibility	  to	  biodegradation	  by	  enzymes	  and	  microorganisms	  (17).	  Hydrolases	  released	  by	  bacteria,	  yeast	  and	  fungi	  can	  degrade	  PCL	  through	  the	  cleavage	  of	  ester	  bonds	  (18). In	  a	  series	  of	  in	  vitro	  studies,	  Tay	  et.	  al	  demonstrated	  the	  biodegradation	  of	  Resilon	  and	  PCL	  in	  the	  presence	  of	  abiotic	  factors	  such	  as	  alkaline	  hydrolases	  and	  biotic	  factors	  including	  endodontically	  relevant	  bacteria	  and	  fungi	  (8,12,18).	  Following	  exposure	  to	  dental	  sludge	  consisting	  of	  saliva,	  sputum,	  coagulated	  blood,	  plaque	  and	  calculus,	  enamel,	  dentin	  and	  shavings	  from	  restorative	  procedures,	  compression	  molded	  disks	  of	  Resilon	  and	  PCL	  both	  exhibited	  significant	  surface	  degradation	  compared	  to	  gutta	  percha	  (8).	  	  Emulsified	  Resilon	  was	  shown	  to	  degrade	  in	  the	  presence	  of	  cholesterol	  esterase,	  a	  component	  of	  salivary	  hydrolases	  and	  an	  inflammatory	  –	  cell	  derived	  enzyme	  (12).	  Penetration	  of	  the	  coronal	  and	  apical	  seals	  could	  result	  in	  exposure	  of	  the	  Resilon	  filling	  material	  to	  this	  enzyme	  (12).	  Gutta	  percha	  and	  its	  main	  constituent poly(trans-1,4-isoprene)	  in	  comparison,	  have	  not	  been	  associated	  with	  biodegradation	  by	  microbial	  enzymes	  (19).	  	  	   The	  significance	  of	  Resilon’s	  susceptibility	  to	  biodegradation	  as	  demonstrated	  in	  this	  study	  is	  its	  potential	  impact	  on	  outcome	  of	  Resilon	  obturated	  root	  canals.	  A	  study	  comparing	  Resilon	  and	  gutta	  percha	  obturated	  root	  canals	  with	  follow-­‐	  up	  times	  ranging	  from	  2-­‐25	  months	  indicated statistically indistinguishable differences in clinical outcome 
between the two materials (20). A more recent study comparing Resilon and gutta percha cases 
with a mean recall time of 5.8 years and 6.6 years respectively, found a statistically significant 
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difference in outcome. Of the Resilon obturated teeth, 56% were classified as successful 
compared to 88% of gutta percha obturated teeth (14). With comparable protocol and success 
criteria, it is likely that the significant factor between these two studies is the time to follow-up. 
Should the inferior clinical outcome of Resilon be related to its biodegradation, time may prove 
to be a significant variable in the process. Due to the small N number in our study, we were 
unable to determine the full effect of time on degradation status, thus further studies are needed 
to determine the significance of this factor.  
 Within the limitations of this study, it was determined that the presence of an orifice 
barrier was not protective against degradation. There may be several explanations for these 
findings. Orifice barriers have been shown to result in coronal leakage of varying degrees based 
on material and thickness (21, 22). An alternative explanation is that the source of enzymatic 
degradation is apical. Resilon has been shown to exhibit degradation	  in	  the	  presence	  of	  cholesterol	  esterase,	  a	  component	  of	  salivary	  hydrolases	  and	  an	  inflammatory–	  cell	  derived	  enzyme	  (12). Monocyte-derived macrophages that secrete these enzymes have been shown to 
be present within periapical granulomas associated with endodontically infected teeth (23).   
  While our study demonstrates a higher proportion of degradation of Resilon obturated 
non-healed root canals compared to gutta percha obturated canals, further investigation should 
focus on the analysis of the degraded material to identify its chemical and microbiological 
content. This may provide us with better understanding as to the cause of biodegradation and its 
potential impact on the patient’s health. It is also important to detect factors associated with non-
healed degraded cases such as periapical status, quality of coronal seal, and radiographic 
appearance in order to identify teeth with greater likelihood of degradation. When considering 
the lack of clinical data surrounding Resilon before its acceptance by the dental community, 
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some concern exists. Resilon should serve as a reminder to stress the need for clinical outcome 
studies in the implementation of new products.  
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MANUSCRIPT	  2:	  RESILON:	  A	  CASE	  SERIES	  OF	  RETREATMENTS	  OF	  NON-­‐HEALED	  CASES	  	  	  
Introduction	  
	  	   Resilon	  is	  a	  thermoplastic	  synthetic	  polymer	  based	  root	  canal	  filling	  material	  that	  was	  introduced	  as	  a	  replacement	  for	  traditionally	  used	  gutta	  percha	  in	  2004	  (1).	  When	  used	  in	  combination	  with	  Epiphany	  sealer	  and	  a	  self-­‐etching	  primer,	  Resilon	  was	  designed	  to	  form	  an	  alleged	  monoblock	  with	  dentin,	  aiming	  for	  a	  superior	  obturation	  resistant	  to	  bacterial	  leakage	  (2)	  and	  increased	  fracture	  resistance	  of	  the	  root	  canal	  treated	  tooth	  (3).	  	  	   Although	  initial	  studies	  showed	  Resilon	  having	  improved	  characteristics	  over	  gutta	  percha	  (2-­‐4),	  several	  investigators	  began	  publishing	  in	  vitro	  studies	  demonstrating	  the	  biodegradation	  of	  Resilon	  in	  the	  presence	  of	  abiotic	  factors	  such	  as	  alkaline	  hydrolases	  and	  biotic	  factors	  including	  endodontically	  relevant	  bacteria	  and	  fungi	  (5-­‐7).	  This	  is	  likely	  attributed	  to	  the	  inclusion	  of	  polycaprolactone,	  a	  biodegradable	  aliphatic	  polyester,	  in	  the	  Resilon	  formulation	  (5).	  PCL	  accounts	  for	  Resilon’s	  thermoplasticity	  and	  is	  susceptible	  to	  biodegradation	  through	  the	  cleavage	  of	  ester	  bonds	  (5).	  Degradation	  of	  Resilon	  may	  be	  a	  contributing	  factor	  to	  its	  higher	  clinical	  failure	  rate	  reported	  in	  a	  recent	  study	  comparing	  long-­‐term	  clinical	  outcomes	  of	  Resilon	  and	  gutta	  percha	  obturated	  root	  canals	  (8).	  	  	   Should	  a	  non-­‐healed	  Resilon	  filled	  tooth	  require	  a	  retreatment,	  significant	  concern	  also	  exists	  over	  the	  increased	  potential	  for	  flare-­‐ups	  due	  to	  the	  potentially	  degraded	  status	  of	  the	  Resilon.	  While	  most	  patients	  return	  to	  normal	  function	  and	  experience	  a	  significant	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relief	  of	  pain	  following	  endodontic	  therapy,	  some	  patients	  may	  experience	  an	  acute	  exacerbation	  of	  severe	  pain	  and/or	  swelling	  requiring	  an	  unscheduled	  visit	  and	  active	  treatment	  known	  as	  a	  flare-­‐up	  (9).	  Retreatments	  in	  particular	  have	  been	  associated	  with	  a	  higher	  prevalence	  of	  inter-­‐appointment	  emergencies	  (10–12).	  	  A	  study	  looking	  at	  retreatments	  of	  teeth	  with	  resorcinol-­‐formaldehyde	  fillings	  noted	  a	  significantly	  higher	  than	  normal	  incidence	  of	  flare-­‐ups	  (13).	  Due	  to	  the	  potential	  biodegradation	  of	  Resilon	  within	  the	  root	  canal,	  Resilon	  retreatments	  may	  present	  with	  comparable	  flare-­‐up	  incidence	  to	  paste	  retreatments.	  	  	   Throughout	  the	  literature,	  there	  is	  still	  little	  information	  to	  guide	  clinicians	  on	  the	  retreatment	  of	  Resilon	  cases	  including	  clinical	  presentation,	  challenges	  with	  removal,	  and	  flare-­‐ups.	  This	  series	  aims	  to	  contribute	  to	  the	  knowledge	  of	  the	  clinical	  approaches	  of	  Resilon	  retreatments	  by	  describing	  three	  clinical	  cases.	  	  	  
Case	  Reports	  	   This	  article	  describes	  three	  cases	  of	  Resilon	  retreatments	  performed	  at	  the	  Graduate	  Endodontic	  Department	  at	  the	  University	  of	  North	  Carolina	  School	  of	  Dentistry	  (UNC-­‐SOD).	  	  Each	  case	  described	  was	  obturated	  previously	  with	  Resilon/Epiphany	  according	  to	  the	  Electronic	  Patient	  Record.	  Clinical	  and	  radiographic	  exams	  were	  performed	  along	  with	  endodontic	  diagnostic	  testing	  at	  a	  consultation	  visit,	  and	  each	  case	  was	  recommended	  for	  retreatment	  due	  to	  the	  patient	  presenting	  with	  clinical	  signs	  or	  symptoms	  or	  an	  enlarging	  periapical	  radiolucency.	  All	  retreatments	  were	  performed	  under	  adequate	  anesthesia	  and	  rubber	  dam	  isolation	  with	  the	  consent	  of	  the	  patient.	  Upon	  access	  of	  the	  previous	  Resilon	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filling	  material,	  the	  same	  instrumentation	  and	  irrigation	  protocol	  was	  used	  to	  remove	  the	  existing	  Resilon	  and	  clean/shape	  the	  canals.	  This	  protocol	  is	  described	  below:	  	  	   A	  15K	  file	  was	  used	  to	  obtain	  an	  apical	  glide	  path	  and	  determine	  working	  length	  (WL)	  using	  an	  ApexID	  apex	  locator.	  Protaper	  Universal	  retreatment	  rotary	  instruments	  were	  used	  in	  the	  coronal	  and	  middle	  third	  of	  the	  canals.	  Hedstrom	  files	  were	  used	  to	  remove	  Resilon	  from	  the	  apical	  third	  of	  the	  canals.	  Irrigation	  involved	  the	  use	  of	  4%	  NaOCl	  with	  activation	  using	  an	  EndoActivator.	  No	  solvents	  were	  used	  in	  removal	  of	  the	  Resilon.	  Vortex	  Blue	  files	  were	  used	  sequentially	  to	  enlarge	  and	  shape	  the	  canals	  with	  recapitulation	  with	  a	  size	  10K	  file	  and	  4%	  NaOCl	  irrigation	  between	  files.	  A	  final	  rinse	  was	  performed	  using	  4%	  NaOCl	  and	  17%	  EDTA.	  The	  canals	  were	  dried	  with	  paper	  points	  and	  calcium	  hydroxide	  was	  placed	  to	  WL	  with	  a	  Lentulo	  spiral.	  A	  piece	  of	  sponge	  was	  placed	  over	  the	  orifices	  followed	  by	  Cavit	  and	  FUJI	  9	  to	  seal	  the	  access.	  	  	   At	  the	  conclusion	  of	  the	  first	  visit,	  the	  patient	  was	  provided	  with	  the	  following	  post-­‐operative	  instructions:	  
- It	  is	  normal	  for	  the	  tooth	  and	  the	  area	  around	  the	  tooth	  to	  be	  sore	  for	  the	  first	  24-­‐48	  hours	  
- This	  soreness	  should	  not	  be	  more	  than	  an	  over-­‐the-­‐counter	  analgesic	  can	  control	  ex:	  ibuprofen	  600mg	  Contact	  me	  if:	  
- The	  pain	  is	  severe	  and	  cannot	  be	  controlled	  by	  over-­‐the-­‐counter	  analgesics	  	  
- The	  pain	  is	  persisting	  or	  increasing	  
- You	  notice	  any	  swelling	  developing	  or	  increasing	  
- You	  have	  any	  further	  questions	  or	  concerns	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A	  flare-­‐up	  was	  defined	  as	  the	  patient	  experiencing	  an	  acute	  exacerbation	  of	  severe	  pain	  and/or	  swelling	  requiring	  an	  unscheduled	  visit	  and	  active	  treatment.	  If	  a	  patient	  experienced	  a	  flare-­‐up,	  it	  was	  recorded.	  	  	   At	  the	  next	  scheduled	  appointment,	  the	  root	  canal	  was	  obturated	  with	  gutta	  percha	  and	  AH	  Plus	  sealer	  using	  the	  warm	  vertical	  technique	  and	  the	  retreatment	  was	  completed.	  Described	  in	  detail	  below	  is	  the	  clinical	  presentation	  of	  Resilon	  including	  the	  pattern	  of	  degradation,	  as	  well	  as	  descriptions	  of	  its	  removal	  and	  technical	  challenges,	  and	  the	  occurrence	  of	  flare-­‐ups.	  	  	  
Case	  1	  	   A	  49-­‐year-­‐old	  Hispanic	  female	  with	  medical	  history	  including	  lower	  back	  pain	  for	  which	  she	  takes	  ibuprofen	  600mg	  and	  a	  thyroidectomy	  in	  2015	  for	  which	  she	  takes	  Levothyroxine	  100	  mcg/day	  presented	  to	  UNC-­‐SOD.	  Tooth	  #19	  was	  previously	  root	  canal	  treated	  5	  years	  prior.	  Clinically	  #19	  presented	  with	  intact	  porcelain	  fused	  to	  metal	  crown	  and	  composite	  core	  build-­‐up.	  	  The	  diagnosis	  was	  as	  follows:	  previously	  treated,	  symptomatic	  apical	  periodontitis.	  	   Upon	  access,	  four	  canals	  were	  located,	  two	  mesial	  and	  two	  distal	  canals	  which	  shared	  a	  common	  orifice.	  The	  round	  bur	  made	  a	  drop	  into	  the	  canals	  upon	  penetration	  of	  the	  composite	  and	  a	  potent	  smell	  was	  immediately	  evident.	  The	  Resilon	  in	  all	  four	  canals	  was	  similar	  in	  consistency	  and	  coloration,	  presenting	  as	  soft	  and	  degraded	  with	  predominately	  gray	  coloration	  with	  light	  pink	  material	  intermixed	  (Fig.	  3C).	  A	  15	  K	  file	  was	  inserted	  into	  the	  canals	  and	  was	  able	  to	  be	  immediately	  inserted	  to	  working	  length	  passively	  without	  the	  use	  of	  solvents	  or	  heat.	  While	  using	  the	  Protaper	  Universal	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Retreatment	  Rotary	  instruments	  to	  auger	  Resilon	  from	  the	  coronal	  and	  middle	  thirds,	  the	  material	  wrapped	  around	  the	  files	  in	  ribbons	  and	  travelled	  coronally	  where	  it	  could	  be	  removed	  from	  the	  canals	  in	  segments	  (Fig.	  3D).	  The	  rotary	  was	  circumferentially	  scraped	  along	  the	  walls	  of	  the	  canals	  and	  was	  able	  to	  remove	  the	  bulk	  of	  the	  material,	  however	  a	  gray	  film	  was	  smeared	  around	  the	  canal	  walls	  and	  could	  not	  be	  removed	  with	  instrumentation.	  A	  Hedstrom	  was	  scraped	  along	  the	  walls	  and	  in	  the	  apical	  third,	  to	  remove	  the	  remaining	  material,	  but	  the	  film	  along	  the	  walls	  remained.	  	  The	  texture	  and	  density	  of	  the	  Resilon	  was	  consistent	  throughout	  the	  entire	  length	  of	  the	  canals.	  	  The	  smeared	  layer	  of	  Resilon	  was	  not	  loosened	  from	  the	  canal	  walls	  until	  the	  sonic	  activator	  was	  used	  in	  each	  canal	  with	  NaOCl.	  During	  activation,	  the	  irrigant	  turned	  gray	  and	  small	  debris	  could	  be	  seen	  floating.	  	  After	  a	  rinse	  with	  NaOCl	  and	  EDTA,	  the	  majority	  of	  the	  walls	  were	  residue	  free	  and	  clean.	  Some	  extrusion	  of	  the	  material	  was	  noted	  radiographically.	  Following	  the	  initial	  retreatment	  visit,	  the	  patient	  did	  not	  experience	  a	  flare-­‐up.	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Figure	  3:	  Radiographs	  and	  images	  from	  Case	  1	  (A)	  Pre-­‐operative	  radiograph	  	  (B)	  Post-­‐	  operative	  radiograph	  of	  retreatment	  (C)	  Image	  of	  Resilon	  in	  distal	  canals	  	  (D)	  Resilon	  debris	  removed	  with	  a	  D3	  rotary	  instrument	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Case	  2	  	   	  	   A	  43-­‐year-­‐old	  Caucasian	  female	  with	  non-­‐contributory	  medical	  history	  presented	  to	  UNC-­‐SOD.	  Tooth	  #8	  received	  primary	  root	  canal	  therapy	  12	  years	  prior.	  The	  patient	  presented	  with	  a	  lingual	  IRM	  with	  clinically	  open	  margins	  that	  was	  placed	  at	  the	  time	  of	  treatment.	  The	  crown	  was	  discolored	  with	  a	  gray	  hue	  compared	  to	  the	  adjacent	  teeth.	  The	  diagnosis	  was	  as	  follows:	  previously	  treated,	  symptomatic	  apical	  periodontitis.	  	  	   Upon	  removal	  of	  the	  IRM,	  a	  very	  potent	  smell	  was	  noted.	  The	  walls	  of	  the	  chamber	  were	  stained	  gray.	  The	  consistency	  of	  the	  Resilon	  was	  particularly	  soft	  and	  mushy,	  with	  a	  similar	  consistency	  of	  a	  wet	  paste	  (Fig	  4C).	  	  It	  was	  gray	  in	  coloration	  intermixed	  with	  white	  flecks.	  After	  removing	  the	  15K	  file	  that	  was	  passively	  inserted	  to	  working	  length,	  a	  wet	  gray	  residue	  was	  noted	  that	  stuck	  to	  the	  flutes	  	  (Fig.	  4D).	  Rather	  than	  coming	  out	  in	  ribbons	  or	  segments	  when	  using	  the	  retreatment	  rotary	  instrument	  and	  Hedstroms,	  the	  material	  seemed	  to	  mush	  together	  and	  create	  a	  sludge	  within	  the	  canal.	  This	  was	  removed	  more	  effectively	  with	  NaOCl	  irrigation	  and	  EndoActivator	  than	  with	  instrumentation,	  which	  made	  the	  material	  smear	  along	  the	  canal	  walls.	  Some	  extrusion	  of	  the	  material	  was	  noted	  radiographically.	  Following	  the	  initial	  retreatment	  visit,	  the	  patient	  did	  not	  experience	  a	  flare-­‐up.	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Figure	  4:	  Radiographs	  and	  images	  from	  Case	  2	  (A)	  Pre-­‐operative	  radiograph	  	  (B)	  Post-­‐operative	  radiograph	  of	  retreatment	  (C)	  Image	  of	  Resilon	  upon	  access	  	  with	  size	  15K	  file	  being	  inserted	  passively	  to	  working	  length	  	  (D)	  Resilon	  debris	  on	  a	  size	  15K	  file	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Case	  3:	  	  
	   A	  20-­‐year-­‐old	  Caucasian	  female	  with	  a	  penicillin	  allergy	  and	  no	  other	  contributory	  medical	  history	  presented	  to	  UNC-­‐SOD. Tooth	  #3	  was	  previously	  root	  canal	  treated	  7	  years	  prior.	  Clinically	  #3	  presented	  with	  an	  acrylic	  provisional	  crown	  and	  FUJI	  build-­‐up.	  	  The	  diagnosis	  was	  as	  follows:	  previously	  treated,	  symptomatic	  apical	  periodontitis.	  	   Upon	  access,	  intact	  PermaFlo	  Purple	  composite	  orifice	  barriers	  were	  found	  covering	  four	  canals.	  Upon	  penetration	  of	  the	  orifice	  barriers,	  a	  potent	  smell	  was	  again	  noted	  that	  was	  significant	  enough	  for	  the	  patient	  to	  inquire	  about.	  The	  Resilon	  was	  discolored	  in	  all	  four	  canals,	  predominately	  dark	  gray	  (Fig	  5C&D),	  The	  material	  was	  degraded	  in	  the	  mesial	  and	  palatal	  canals,	  however	  it	  was	  slightly	  more	  dense	  in	  the	  distal	  canal	  as	  determined	  by	  the	  15	  K	  file	  requiring	  some	  apical	  pressure	  to	  penetrate.	  As	  the	  file	  approached	  the	  middle	  third	  of	  the	  canal,	  the	  material	  became	  softer	  and	  an	  apical	  glide	  path	  was	  obtained	  passively.	  The	  retreatment	  rotary	  instrument	  augured	  the	  majority	  of	  the	  filling	  material	  from	  the	  coronal	  and	  middle	  thirds	  in	  segments	  (Fig.	  5E).	  In	  the	  coronal	  of	  the	  distal	  canal,	  the	  material	  came	  out	  in	  more	  solid	  chunks	  than	  in	  the	  middle	  and	  apical	  third	  of	  the	  canal.	  Hedstroms	  were	  successful	  in	  removing	  the	  material	  in	  the	  apical	  third.	  When	  wiping	  the	  files	  on	  a	  piece	  of	  4x4	  gauze	  after	  inserting	  them	  into	  the	  canals,	  a	  dark	  gray	  residue	  was	  left	  behind	  similar	  to	  that	  which	  was	  smeared	  on	  the	  walls	  of	  the	  canals	  (Fig	  5F).	  While	  the	  bulk	  of	  the	  filling	  material	  was	  removed,	  some	  of	  the	  smeared	  residue	  along	  the	  walls	  and	  in	  isthmuses/fins	  was	  left	  behind.	  	  Again,	  solvents	  were	  not	  used	  for	  removal	  as	  it	  seemed	  they	  would	  result	  in	  more	  smearing	  of	  the	  filling	  material.	  The	  remaining	  retreatment	  protocol	  was	  continued	  as	  described	  above.	  	  Following	  the	  initial	  visit,	  the	  patient	  did	  not	  experience	  a	  flare-­‐up.	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Figure	  5: Radiographs	  and	  images	  from	  Case	  3	  (A)	  Pre-­‐operative	  radiograph	  	  (B)	  Post-­‐	  operative	  radiograph	  of	  retreatment	  (C)	  Image	  of	  degraded	  Resilon	  	  in	  canals	  upon	  access	  through	  intraorifice	  barriers	  (D)	  Image	  of	  degraded	  	  Resilon	  in	  canals	  upon	  access	  through	  intraorifice	  barriers	  	  (E)	  D3	  Protaper	  Retreatment	  Rotary	  file	  with	  Resilon	  debris	  	  (F)	  4x4	  gauze	  after	  wiping	  Resilon	  debris	  off	  of	  a	  file	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Discussion	  	   	  In	  the	  present	  case	  series,	  non-­‐healed	  cases	  obturated	  previously	  with	  Resilon/	  Epiphany	  were	  described	  in	  detail	  including	  the	  pattern	  of	  degradation,	  as	  well	  as	  descriptions	  of	  its	  removal	  and	  technical	  challenges,	  and	  the	  occurrence	  of	  flare-­‐ups.	  While	  every	  retreatment	  is	  different,	  each	  with	  its	  own	  unique	  clinical	  challenges,	  these	  three	  cases	  are	  representative	  of	  the	  experience	  of	  retreating	  Resilon	  that	  has	  degraded.	  	  	  	   One	  potential	  explanation	  for	  the	  degradation	  exhibited	  in	  these	  retreatments	  may	  be	  the	  inclusion	  of	  the	  biodegradable	  polyester	  polycaprolactone	  (PCL)	  in	  the	  Resilon	  formulation	  (6).	  PCL	  has	  traditionally	  been	  used	  as	  a	  component	  in	  drug-­‐	  delivery	  devices	  due	  to	  its	  low	  melting	  point,	  biocompatibility,	  and	  susceptibility	  to	  biodegradation	  by	  enzymes	  and	  microorganisms	  (14).	  Hydrolases	  released	  by	  bacteria,	  yeast	  and	  fungi	  can	  result	  in	  the	  biodegradation	  of	  PCL	  through	  the	  cleavage	  of	  ester	  bonds	  (15). In	  a	  series	  of	  in	  vitro	  studies,	  the	  biodegradation	  of	  Resilon	  and	  PCL	  were	  demonstrated	  in	  the	  presence	  of	  abiotic	  factors	  such	  as	  alkaline	  hydrolases	  and	  biotic	  factors	  including	  endodontically	  relevant	  bacteria	  and	  fungi	  (5-­‐7).	  Following	  exposure	  to	  dental	  sludge	  consisting	  of	  saliva,	  sputum,	  coagulated	  blood,	  plaque	  and	  calculus,	  enamel,	  dentin	  and	  shavings	  from	  restorative	  procedures,	  compression	  molded	  disks	  of	  Resilon	  and	  PCL	  both	  exhibited	  significant	  surface	  degradation	  compared	  to	  gutta	  percha	  (5).	  	  Emulsified	  Resilon	  was	  shown	  to	  degrade	  in	  the	  presence	  of	  cholesterol	  esterase,	  a	  component	  of	  salivary	  hydrolases	  and	  an	  inflammatory	  –	  cell	  derived	  enzyme	  (6).	  Monocyte-derived macrophages 
that secrete these enzymes have been shown to be present within periapical granulomas 
associated with endodontically infected teeth (16). This presents a possible explanation for the 
degradation noted in Case 1 and 3 in which a crown with clinically sound margins and intact 
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orifice barriers were found. In Case 3, the degradation of Resilon also appeared to progress 
towards the apical third of the distal canal and was more intact coronally. These findings 
contradict our initial prediction that orifice barriers and an adequate coronal seal would be 
protective against degradation and support the theory that the source of enzymatic degradation 
may be derived from the periapex.  
 The experience of retreating these Resilon cases was different than traditional gutta 
percha retreatments and hard paste retreatments. Establishing apical patency was done passively 
and removal of the filling material required no solvents or ultrasonic instrumentation. This 
differs from some of the reports in the literature describing the removal of pastes such as N2 or 
silver points which may require the use of ultrasonics and additional armamentarium and can be 
time-consuming (17-19). In a systematic review comparing gutta percha retreatment techniques, 
it was found that solvents enhanced file penetration but hindered canal cleanliness (20). Solvents 
were not used during these Resilon retreatments because file penetration to the apex was not a 
challenge due to its degraded consistency. When considering the time for and effectiveness of 
removal, our findings are consistent with previous reports in the literature that Resilon/ Epiphany 
can be removed quickly, however compared to gutta percha, leaves behind more residual 
material (21,22). In all of the cases in this series, a smear of Resilon was left covering portions of 
the canal walls.  
 The lack of flare-ups experienced by the patients in this series contradicts the literature, 
which reports a higher likelihood following retreatments (10,11). Gound et al. reported a higher 
than normal number of flare-ups following the retreatment of resorcinol-formaldehyde filled root 
canal retreatments (13). One explanation for the absence of flare-ups experienced in our case 
series is the lack of severe presenting symptoms. Many studies have identified pre-operative pain 
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and swelling as significant factors predisposing patients to flare-ups (9, 12). While the 
mechanisms of flare-ups are still not fully understood, evidence suggests that microbial factors 
play a significant role (23,24). It is possible that the environment created by the degraded 
Resilon may reduce the virulence of specific bacterial species involved in flare-ups.    
 The information and experience presented in this case series will hopefully aid 
practitioners in navigating the retreatment of a non-healed Resilon obturated root canals and 
allow them to provide the patient with appropriate expectations as to the potential for flare-ups.  
The degradation of Resilon into the paste-like material described in this case series facilitates 
sampling and analysis of the material in future studies to identify its chemical and 
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   This	  thesis	  addresses	  the	  AAE	  research	  priority	  of	  the	  effect	  of	  obturation	  techniques	  on	  endodontic	  success.	  	  In	  part	  1	  of	  this	  study,	  the	  proportion	  of	  clinically	  degraded	  Resilon/	  Epiphany	  in	  non-­‐healed	  endodontic	  cases	  receiving	  retreatment	  was	  investigated.	  Previous	  in	  vitro	  studies	  provided	  hypotheses	  to	  the	  higher	  clinical	  failure	  rate	  of	  Resilon	  obturated	  root	  canals	  found	  in	  the	  Barborka	  et.	  al	  study	  including	  the	  susceptibility	  of	  Resilon	  and	  its	  components	  to	  degradation,	  	  however	  this	  was	  the	  first	  study	  to	  show	  clinical	  proof	  of	  this	  degradation	  (1-­‐4).	  It	  was	  found	  that	  78%	  of	  Resilon	  obturated	  canals	  were	  degraded	  compared	  to	  0%	  of	  gutta	  percha	  obturated	  canals.	  Part	  2	  of	  this	  thesis,	  describes	  a	  series	  of	  cases	  in	  which	  non-­‐	  healed	  Resilon	  obturated	  root	  canals	  were	  retreated.	  Detailed	  explanations	  of	  the	  pattern	  of	  degradation,	  as	  well	  as	  descriptions	  of	  its	  removal	  and	  technical	  challenges,	  and	  the	  occurrence	  of	  flare-­‐ups	  were	  provided.	  In 
contrast to other studies that found a higher percentage of flare-ups among patients receiving  
retreatments of traditional gutta percha or paste fills, these Resilon retreatments did not result in 
flare-ups.  
 Findings from this clinical observational study have given us insight into the proportion 
of degradation of Resilon that occurs in non-healed cases and a potential explanation for 
Resilon’s higher clinical failure rate. These clinical findings are significant when treatment 
planning non-healed Resilon filled teeth.  The soft paste-like consistency of Resilon resulting in 
relatively simple removal during retreatment compared to gutta percha or hard paste fills, as well 
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as the lack of flare-ups following retreatment suggest a potential benefit of electing non- surgical 
retreatment over periapical microsurgery. Future studies could be done to determine the clinical 
success rate of retreated Resilon cases compared to traditional gutta percha retreatments. Further	  investigation	  should	  also	  be	  done	  to	  analyze the degraded Resilon material for its chemical and 
microbiological content, which may provide us with better understanding as to the potential 
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APPENDIX	  A:	  ADULT	  CONSENT	  FORM	  
University	  of	  North	  Carolina	  at	  Chapel	  Hill	  
Consent	  to	  Participate	  in	  a	  Research	  Study	  
Adult	  Participants	  	  	  
Consent	  Form	  Version	  Date:	  09/12/2016	  
IRB	  Study	  #	  16-­‐1069	  
Title	  of	  Study:	  Long-­‐term	  outcome	  assessment	  and	  treatment	  of	  Resilon	  obturation	  system	  compared	  to	  gutta	  percha.	  	  
Principal	  Investigator:	  Peter	  Tawil	  
Principal	  Investigator	  Department:	  Endodontics	  
Principal	  Investigator	  Phone	  number:	  919-­‐537-­‐3403	  
Principal	  Investigator	  Email	  Address:	  pzt@unc.edu	  	  
Co-­‐Investigators:	  Lesleigh	  Payne,	  Krista	  Andersen,	  Ceib	  Phillips,	  Ashraf	  Fouad	  	  _________________________________________________________________	  	  
What	  are	  some	  general	  things	  you	  should	  know	  about	  research	  studies?	  You	  are	  being	  asked	  to	  take	  part	  in	  a	  research	  study.	  	  To	  join	  the	  study	  is	  voluntary.	  You	  may	  refuse	  to	  join,	  or	  you	  may	  withdraw	  your	  consent	  to	  be	  in	  the	  study,	  for	  any	  reason,	  without	  penalty.	  	  Research	  studies	  are	  designed	  to	  obtain	  new	  knowledge.	  This	  new	  information	  may	  help	  people	  in	  the	  future.	  	  	  You	  may	  not	  receive	  any	  direct	  benefit	  from	  being	  in	  the	  research	  study.	  There	  also	  may	  be	  risks	  to	  being	  in	  research	  studies.	  	  	  Details	  about	  this	  study	  are	  discussed	  below.	  	  It	  is	  important	  that	  you	  understand	  this	  information	  so	  that	  you	  can	  make	  an	  informed	  choice	  about	  being	  in	  this	  research	  study.	  	  	  You	  will	  be	  given	  a	  copy	  of	  this	  consent	  form.	  	  You	  should	  ask	  the	  researchers	  named	  above,	  or	  staff	  members	  who	  may	  assist	  them,	  any	  questions	  you	  have	  about	  this	  study	  at	  any	  time.	  	  
What	  is	  the	  purpose	  of	  this	  study?	  The	  purpose	  of	  this	  study	  is	  to	  evaluate	  the	  long-­‐term	  outcome	  of	  root	  canal	  therapy	  at	  the	  UNC	  graduate	  and	  predoctoral	  endodontic	  clinics.	  The	  materials	  used	  for	  treatment	  will	  be	  evaluated	  as	  well	  as	  other	  factors	  that	  could	  affect	  the	  success	  of	  treatment.	  	  	  You	  are	  being	  asked	  to	  be	  in	  the	  study	  because	  you	  have	  had	  root	  canal	  therapy	  completed	  at	  UNC	  School	  of	  Dentistry	  at	  a	  time	  where	  different	  materials	  were	  in	  use.	  	  	  
Are	  there	  any	  reasons	  you	  should	  not	  be	  in	  this	  study?	  You	  should	  not	  be	  in	  this	  study	  if	  you	  are	  under	  the	  age	  of	  18.	  	  	  
How	  many	  people	  will	  take	  part	  in	  this	  study?	  There	  will	  be	  approximately	  1,000	  people	  in	  this	  research	  study.	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How	  long	  will	  your	  part	  in	  this	  study	  last?	  Your	  participation	  in	  the	  research	  study	  will	  last	  as	  long	  as	  you	  are	  receiving	  follow-­‐up	  care	  at	  the	  UNC	  School	  of	  Dentistry,	  which	  may	  range	  from	  one	  to	  four	  visits	  over	  a	  maximum	  of	  three	  months.	  	  Clinical	  information	  gathered	  during	  this	  time	  will	  be	  used	  for	  research	  purposes.	  	  
What	  will	  happen	  if	  you	  take	  part	  in	  the	  study?	  The	  first	  visit	  will	  be	  your	  regular	  (standard	  of	  care)	  follow	  up	  evaluation	  and	  x-­‐ray.	  You	  will	  not	  be	  charged	  for	  this	  visit.	  	  	  If	  you	  are	  not	  having	  problems	  with	  your	  root	  canal	  and	  your	  dentist	  does	  not	  ask	  you	  to	  return	  for	  re-­‐treatment,	  then	  your	  participation	  in	  the	  research	  study	  is	  complete	  and	  we	  will	  use	  your	  past	  dental	  records,	  as	  well	  as	  those	  from	  this	  visit,	  in	  our	  research	  study.	  These	  records	  include	  dental	  history,	  treatment	  notes,	  and	  x-­‐rays.	  If	  your	  dentist	  decides	  that	  you	  need	  re-­‐treatment	  of	  your	  root	  canal,	  then	  the	  researchers	  will	  continue	  to	  use	  the	  clinical	  information	  from	  your	  re-­‐treatment	  visits	  for	  the	  research.	  This	  re-­‐treatment	  is	  not	  part	  of	  the	  research	  study	  and	  you	  will	  be	  responsible	  for	  the	  cost	  of	  re-­‐treatment,	  which	  ranges	  from	  $525.000	  to	  $750.00.	  In	  addition,	  you	  will	  be	  given	  a	  10-­‐minute	  questionnaire	  to	  complete	  at	  home	  and	  return	  to	  the	  researchers	  at	  your	  last	  clinic	  visit.	  	  This	  questionnaire	  will	  ask	  you	  to	  record	  any	  post-­‐operative	  pain	  or	  swelling	  that	  occurred,	  as	  well	  as	  any	  pain	  medicine	  taken	  for	  the	  first	  72	  hours	  after	  treatment.	  You	  may	  choose	  not	  to	  answer	  a	  question	  for	  any	  reason.	  	  The	  dentist	  who	  treats	  you	  will	  be	  responsible	  for	  your	  welfare	  during	  the	  study.	  	  
What	  are	  the	  possible	  benefits	  from	  being	  in	  this	  study?	  Research	  is	  designed	  to	  benefit	  society	  by	  gaining	  new	  knowledge.	  You	  will	  not	  benefit	  personally	  from	  being	  in	  this	  research	  study.	  	  	  
What	  are	  the	  possible	  risks	  or	  discomforts	  involved	  from	  being	  in	  this	  study?	  There	  are	  no	  foreseen	  immediate	  or	  long-­‐term	  physical,	  psychological,	  or	  social	  risks/discomforts	  from	  participating	  in	  the	  research.	  There	  is	  a	  slight	  risk	  of	  a	  breach	  of	  confidentiality	  of	  your	  dental	  information.	  	  To	  prevent	  this,	  any	  information	  that	  we	  collect	  will	  not	  contain	  your	  name	  or	  any	  other	  identifying	  information.	  	  You	  will	  be	  assigned	  a	  research	  ID	  code.	  	  This	  code	  will	  be	  used	  on	  all	  of	  your	  data	  and	  on	  your	  questionnaire.	  	  In	  addition,	  all	  information	  will	  be	  kept	  on	  a	  password-­‐protected	  computer	  or	  in	  a	  locked	  office,	  with	  only	  research	  personnel	  having	  access.	  There	  may	  be	  uncommon	  or	  previously	  unknown	  risks.	  You	  should	  report	  any	  problems	  to	  the	  researcher.	  	  
What	  if	  we	  learn	  about	  new	  findings	  or	  information	  during	  the	  study?	  	  You	  will	  be	  given	  any	  new	  information	  gained	  during	  the	  course	  of	  the	  study	  that	  might	  affect	  your	  willingness	  to	  continue	  your	  participation.	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How	  will	  information	  about	  you	  be	  protected?	  	  	  Every	  effort	  will	  be	  made	  to	  protect	  your	  privacy.	  All	  information	  collected	  in	  this	  study	  will	  remain	  confidential	  and	  only	  those	  directly	  involved	  in	  the	  study	  will	  have	  access	  to	  this	  information.	  Participants	  will	  not	  be	  identified	  in	  any	  report	  or	  publication	  about	  this	  study.	  Although	  every	  effort	  will	  be	  made	  to	  keep	  research	  records	  private,	  there	  may	  be	  times	  when	  federal	  or	  state	  law	  requires	  the	  disclosure	  of	  such	  records,	  including	  personal	  information.	  	  This	  is	  very	  unlikely,	  but	  if	  disclosure	  is	  ever	  required,	  UNC-­‐Chapel	  Hill	  will	  take	  steps	  allowable	  by	  law	  to	  protect	  the	  privacy	  of	  personal	  information.	  	  In	  some	  cases,	  your	  information	  in	  this	  research	  study	  could	  be	  reviewed	  by	  representatives	  of	  the	  University,	  research	  sponsors,	  or	  government	  agencies	  (for	  example,	  the	  FDA)	  for	  purposes	  such	  as	  quality	  control	  or	  safety.	  	  
What	  will	  happen	  if	  you	  are	  injured	  by	  this	  research?	  All	  research	  involves	  a	  chance	  that	  something	  bad	  might	  happen	  to	  you.	  	  This	  may	  include	  the	  risk	  of	  personal	  injury.	  In	  spite	  of	  all	  safety	  measures,	  you	  might	  develop	  a	  reaction	  or	  injury	  from	  being	  in	  this	  study.	  If	  such	  problems	  occur,	  the	  researchers	  will	  help	  you	  get	  medical	  care,	  but	  any	  costs	  for	  the	  medical	  care	  will	  be	  billed	  to	  you	  and/or	  your	  insurance	  company.	  The	  University	  of	  North	  Carolina	  at	  Chapel	  Hill	  has	  not	  set	  aside	  funds	  to	  pay	  you	  for	  any	  such	  reactions	  or	  injuries,	  or	  for	  the	  related	  medical	  care.	  You	  do	  not	  give	  up	  any	  of	  your	  legal	  rights	  by	  signing	  this	  form.	  	  
What	  if	  you	  want	  to	  stop	  before	  your	  part	  in	  the	  study	  is	  complete?	  You	  can	  withdraw	  from	  this	  study	  at	  any	  time,	  without	  penalty.	  	  The	  investigators	  also	  have	  the	  right	  to	  stop	  your	  participation	  at	  any	  time.	  This	  could	  be	  because	  you	  have	  had	  an	  unexpected	  reaction,	  or	  have	  failed	  to	  follow	  instructions,	  or	  because	  the	  entire	  study	  has	  been	  stopped.	  
	  
Will	  you	  receive	  anything	  for	  being	  in	  this	  study?	  You	  will	  not	  receive	  anything	  from	  being	  in	  this	  study.	  
	  
Will	  it	  cost	  you	  anything	  to	  be	  in	  this	  study?	  It	  will	  not	  cost	  you	  anything	  to	  be	  in	  this	  study.	  	  	  
What	  if	  you	  have	  questions	  about	  this	  study?	  You	  have	  the	  right	  to	  ask,	  and	  have	  answered,	  any	  questions	  you	  may	  have	  about	  this	  research.	  If	  you	  have	  questions	  about	  the	  study	  (including	  payments),	  complaints,	  concerns,	  or	  if	  a	  research-­‐related	  injury	  occurs,	  you	  should	  contact	  the	  researchers	  listed	  on	  the	  first	  page	  of	  this	  form.	  	  
What	  if	  you	  have	  questions	  about	  your	  rights	  as	  a	  research	  participant?	  All	  research	  on	  human	  volunteers	  is	  reviewed	  by	  a	  committee	  that	  works	  to	  protect	  your	  rights	  and	  welfare.	  	  If	  you	  have	  questions	  or	  concerns	  about	  your	  rights	  as	  a	  research	  subject,	  or	  if	  you	  would	  like	  to	  obtain	  information	  or	  offer	  input,	  you	  may	  contact	  the	  Institutional	  Review	  Board	  at	  919-­‐966-­‐3113	  or	  by	  email	  to	  IRB_subjects@unc.edu.	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Participant’s	  Agreement:	  	  I	  have	  read	  the	  information	  provided	  above.	  	  I	  have	  asked	  all	  the	  questions	  I	  have	  at	  this	  time.	  	  I	  voluntarily	  agree	  to	  participate	  in	  this	  research	  study.	  	  ______________________________________________________	  Signature	  of	  Research	  Participant	  
	  	  	  	  ____________________	  	  	  	  Date	  
	  ______________________________________________________	  Printed	  Name	  of	  Research	  Participant	   	  	  	   	  ______________________________________________________	  Signature	  of	  Research	  Team	  Member	  Obtaining	  Consent	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APPENDIX	  B:	  HIPPAA	  AUTHORIZATION	  
University	  of	  North	  Carolina	  at	  Chapel	  Hill	  	  
	  
HIPAA	  Authorization	  for	  Use	  and	  Disclosure	  of	  Health	  Information	  for	  Research	  
Purposes	   	  
IRB	  Study	  #	  16-­‐1069	  
Title	  of	  Study:	  Long-­‐term	  outcome	  assessment	  and	  treatment	  of	  Resilon	  obturation	  system	  compared	  to	  Gutta	  Percha,	  	  
Principal	  Investigator:	  Peter	  Tawil	  
Mailing	  Address	  for	  UNC-­‐Chapel	  Hill	  Department:	  CB:	  	   	  This	  is	  a	  permission	  called	  a	  “HIPAA	  authorization.”	  It	  is	  required	  by	  the	  “Health	  Insurance	  Portability	  and	  Accountability	  Act	  of	  1996”	  (known	  as	  “HIPAA”)	  in	  order	  for	  us	  to	  get	  information	  from	  your	  medical	  records	  or	  health	  insurance	  records	  to	  use	  in	  this	  research	  study.	   	  1.	  If	  you	  sign	  this	  HIPAA	  authorization	  form,	  you	  are	  giving	  your	  permission	  for	  the	  following	  people	  or	  groups	  to	  give	  the	  researchers	  certain	  information	  about	  you	  (described	  below):	  	  Any	  health	  care	  providers	  or	  health	  care	  professionals	  or	  health	  plans	  that	  have	  provided	  health	  services,	  treatment,	  or	  payment	  for	  you	  such	  as	  physicians,	  clinics,	  hospitals,	  home	  health	  agencies,	  diagnostics	  centers,	  laboratories,	  treatment	  or	  surgical	  centers,	  including	  but	  not	  limited	  to	  the	  UNC	  Health	  Care	  System	  and	  its	  members	  and	  affiliates	  (collectively,	  “UNCHCS”),	  health	  insurance	  plans,	  and	  government	  health	  agencies.	  	  2.	  If	  you	  sign	  this	  form,	  this	  is	  the	  health	  information	  about	  you	  that	  the	  people	  or	  groups	  listed	  in	  #1	  may	  give	  to	  the	  researchers	  to	  use	  in	  this	  research	  study:	  	  Any	  information	  in	  your	  medical	  records	  that	  relates	  to	  your	  participation	  in	  this	  research.	  This	  information	  may	  include	  medical	  and	  dental	  health	  history,	  clinic	  notes,	  radiographs,	  and	  clinic	  visit	  schedule.	  	  3.	  The	  HIPAA	  protections	  that	  apply	  to	  your	  medical	  records	  will	  not	  apply	  to	  your	  information	  when	  it	  is	  in	  the	  research	  study	  records.	  Your	  information	  in	  the	  research	  study	  records	  may	  also	  be	  shared	  with,	  used	  by	  or	  seen	  by	  collaborating	  researchers,	  the	  sponsor	  of	  the	  research	  study,	  the	  sponsor’s	  representatives,	  and	  certain	  employees	  of	  the	  University	  of	  North	  Carolina	  at	  Chapel	  Hill	  or	  other	  affiliated	  entities	  conducting	  the	  research,	  or	  government	  agencies	  (like	  the	  FDA)	  if	  needed	  to	  oversee	  the	  research	  study.	  HIPAA	  rules	  do	  not	  usually	  apply	  to	  those	  people	  or	  groups.	  If	  any	  of	  these	  people	  or	  groups	  reviews	  your	  research	  record,	  they	  may	  also	  need	  to	  review	  portions	  of	  your	  original	  medical	  record	  relevant	  to	  the	  situation.	  The	  informed	  consent	  document	  describes	  the	  procedures	  in	  this	  research	  study	  that	  will	  be	  used	  to	  protect	  your	  personal	  information.	  You	  can	  also	  ask	  the	  researchers	  any	  questions	  about	  what	  they	  will	  do	  with	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your	  personal	  information	  and	  how	  they	  will	  protect	  your	  personal	  information	  in	  this	  research	  study.	  	  4.	  If	  this	  research	  study	  creates	  medical	  information	  about	  you	  that	  will	  go	  into	  your	  medical	  record,	  you	  may	  not	  be	  able	  to	  see	  the	  research	  study	  information	  in	  your	  medical	  record	  until	  the	  entire	  research	  study	  is	  over.	  	  5.	  If	  you	  want	  to	  participate	  in	  this	  research	  study,	  you	  must	  sign	  this	  HIPAA	  authorization	  form	  to	  allow	  the	  people	  or	  groups	  listed	  in	  #1on	  this	  form	  to	  give	  access	  to	  the	  information	  about	  you	  that	  is	  listed	  in	  #2.	  If	  you	  do	  not	  want	  to	  sign	  this	  HIPAA	  authorization	  form,	  you	  cannot	  participate	  in	  this	  research	  study.	  However,	  not	  signing	  the	  authorization	  form	  will	  not	  change	  your	  right	  to	  treatment,	  payment,	  enrollment	  or	  eligibility	  for	  medical	  services	  outside	  of	  this	  research	  study.	  	  6.	  This	  HIPAA	  authorization	  will	  not	  stop	  unless	  you	  stop	  it	  in	  writing.	  	  7.	  You	  have	  the	  right	  to	  stop	  this	  HIPAA	  authorization	  at	  any	  time.	  You	  must	  do	  that	  in	  writing.	  You	  may	  give	  your	  written	  stop	  of	  this	  HIPAA	  authorization	  directly	  to	  Principal	  Investigator	  or	  researcher	  or	  you	  may	  mail	  it	  to	  the	  department	  mailing	  address	  listed	  at	  the	  top	  of	  this	  form,	  or	  you	  may	  give	  it	  to	  one	  of	  the	  researchers	  in	  this	  study	  and	  tell	  the	  researcher	  to	  send	  it	  to	  any	  person	  or	  group	  the	  researcher	  has	  given	  a	  copy	  of	  this	  HIPAA	  authorization.	  Stopping	  this	  HIPAA	  authorization	  will	  not	  stop	  information	  sharing	  that	  has	  already	  happened.	  	  8.	  You	  will	  be	  given	  a	  copy	  of	  this	  signed	  HIPAA	  authorization.	  	   __________________________________________________	  Signature	  of	  Research	  Participant	   _____________________	  Date	  
	  __________________________________________________	  Printed	  Name	  of	  Research	  Participant	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APPENDIX	  C:	  IRB	  APPROVAL	  LETTER	  
To:	  Peter	  Tawil	  Endodontics	  	  
From:	  Biomedical	  IRB	  	  
Approval	  Date:	  9/20/2016	  
Expiration	  Date	  of	  Approval:	  9/19/2017	  
RE:	  Notice	  of	  IRB	  Approval	  by	  Expedited	  Review	  (under	  45	  CFR	  46.110)	  
Submission	  Type:	  Initial	  
Expedited	  Category:	  5.Existing	  or	  non-­‐research	  data,7.Surveys/interviews/focus	  groups	  
Study	  #:	  16-­‐1069	  	  
Study	  Title:	  Long-­‐term	  outcome	  assessment	  and	  treatment	  of	  Resilon	  obturation	  system	  compared	  to	  gutta	  percha.	  	  This	  submission	  has	  been	  approved	  by	  the	  IRB	  for	  the	  period	  indicated.	  It	  has	  been	  determined	  that	  the	  risk	  involved	  in	  this	  research	  is	  no	  more	  than	  minimal.	  	  	  
Study	  Description:	  Purposes:	  To	  assess	  the	  long-­‐term	  outcome	  and	  treatment	  of	  Resilon/Epiphany	  filled	  root	  canals	  compared	  to	  gutta	  percha	  filled	  root	  canals	  	  Participants:	  Patients	  from	  the	  University	  of	  North	  Carolina	  School	  of	  Dentistry	  who	  received	  root	  canal	  therapy	  (dental	  codes	  D3310,	  D3320,	  D3330,	  D3999,	  D3346,	  D3347,	  D3348)	  that	  was	  completed	  using	  Resilon/Epiphany	  obturation	  system	  or	  gutta	  percha	  from	  August	  1,	  2004	  -­‐	  August	  31,	  2013.	  	  	  Procedures:	  Electronic	  patient	  records	  will	  be	  reviewed,	  the	  standard	  of	  care	  radiographs	  will	  be	  scored,	  and	  a	  written	  survey	  will	  be	  conducted	  of	  a	  subset	  of	  the	  participants.	  	  	  	  
Regulatory	  and	  other	  findings:	  The	  IRB	  has	  determined	  that	  the	  study-­‐specific	  rationale	  provided	  by	  the	  investigator	  is	  sufficient	  to	  justify	  a	  limited	  waiver	  of	  HIPAA	  authorization	  to	  identify	  potential	  subjects	  for	  recruitment	  into	  this	  research	  study,	  as	  allowed	  under	  45	  CFR	  164.512.	  This	  temporary	  waiver	  provides	  access	  to	  protected	  health	  information	  (PHI)	  to	  confirm	  eligibility	  and	  facilitate	  initial	  contact,	  after	  which	  consent	  and	  HIPAA	  authorization	  will	  be	  sought	  when	  applicable.	  Access	  and	  use	  is	  limited	  to	  the	  minimum	  amount	  of	  PHI	  necessary	  to	  review	  eligibility	  criteria	  and	  to	  contact	  potential	  subjects.	  	  
Investigator’s	  Responsibilities:	  	  Federal	  regulations	  require	  that	  all	  research	  be	  reviewed	  at	  least	  annually.	  It	  is	  the	  Principal	  Investigator’s	  responsibility	  to	  submit	  for	  renewal	  and	  obtain	  approval	  before	  the	  expiration	  date.	  You	  may	  not	  continue	  any	  research	  activity	  beyond	  the	  expiration	  date	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without	  IRB	  approval.	  Failure	  to	  receive	  approval	  for	  continuation	  before	  the	  expiration	  date	  will	  result	  in	  automatic	  termination	  of	  the	  approval	  for	  this	  study	  on	  the	  expiration	  date.	  	  Your	  approved	  consent	  forms	  and	  other	  documents	  are	  available	  online	  at	  http://apps.research.unc.edu/irb/index.cfm?event=home.dashboard.irbStudyManagement&irb_id=16-­‐1069.	  	  You	  are	  required	  to	  obtain	  IRB	  approval	  for	  any	  changes	  to	  any	  aspect	  of	  this	  study	  before	  they	  can	  be	  implemented.	  Any	  unanticipated	  problem	  involving	  risks	  to	  subjects	  or	  others	  (including	  adverse	  events	  reportable	  under	  UNC-­‐Chapel	  Hill	  policy)	  should	  be	  reported	  to	  the	  IRB	  using	  the	  web	  portal	  at	  http://irbis.unc.edu.	  	  	  Please	  be	  aware	  that	  additional	  approvals	  may	  still	  be	  required	  from	  other	  relevant	  authorities	  or	  "gatekeepers"	  (e.g.,	  school	  principals,	  facility	  directors,	  custodians	  of	  records).	  	  The	  current	  data	  security	  level	  determination	  is	  Level	  III.	  Any	  changes	  in	  the	  data	  security	  level	  need	  to	  be	  discussed	  with	  the	  relevant	  IT	  official.	  If	  data	  security	  level	  II	  and	  III,	  consult	  with	  your	  IT	  official	  to	  develop	  a	  data	  security	  plan.	  Data	  security	  is	  ultimately	  the	  responsibility	  of	  the	  Principal	  Investigator.	  	  This	  study	  was	  reviewed	  in	  accordance	  with	  federal	  regulations	  governing	  human	  subjects	  research,	  including	  those	  found	  at	  45	  CFR	  46	  (Common	  Rule),	  45	  CFR	  164	  (HIPAA),	  21	  CFR	  50	  &	  56	  (FDA),	  and	  40	  CFR	  26	  (EPA),	  where	  applicable.	  
 
